Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cue Biopharma (CUE) Return on Assets (2018 - 2025)

Historic Return on Assets for Cue Biopharma (CUE) over the last 8 years, with Q3 2025 value amounting to 1.03%.

  • Cue Biopharma's Return on Assets fell 300.0% to 1.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.03%, marking a year-over-year decrease of 300.0%. This contributed to the annual value of 0.85% for FY2024, which is 2000.0% down from last year.
  • Per Cue Biopharma's latest filing, its Return on Assets stood at 1.03% for Q3 2025, which was down 300.0% from 1.22% recorded in Q2 2025.
  • Over the past 5 years, Cue Biopharma's Return on Assets peaked at 0.47% during Q1 2021, and registered a low of 1.47% during Q1 2025.
  • Over the past 5 years, Cue Biopharma's median Return on Assets value was 0.66% (recorded in 2023), while the average stood at 0.77%.
  • In the last 5 years, Cue Biopharma's Return on Assets surged by 1100bps in 2021 and then crashed by -6200bps in 2025.
  • Cue Biopharma's Return on Assets (Quarter) stood at 0.54% in 2021, then decreased by -17bps to 0.63% in 2022, then fell by -20bps to 0.76% in 2023, then plummeted by -37bps to 1.04% in 2024, then rose by 0bps to 1.03% in 2025.
  • Its last three reported values are 1.03% in Q3 2025, 1.22% for Q2 2025, and 1.47% during Q1 2025.